Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JOSEPH D VILLANACCI

Allopathic & Osteopathic Physicians Internal Medicine Rheumatology

NPI
1609373810
CMS profile
11527755
Location
SAN ANTONIO, TX

General Payments · PY2023–2024

$1,313.94

  • Reported across 42 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,144.11

38 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,144.11 38

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ANI Pharmaceuticals, Inc. $363.62 5
ABBVIE INC. $182.75 11
Amgen Inc. $145.04 3
LivaNova USA, Inc. $113.62 5
UCB, Inc. $111.86 4
NOVARTIS PHARMACEUTICALS CORPORATION $93.87 4
Neurelis, Inc. $31.54 1
ARGENX US, INC. $28.74 1
Octapharma USA, Inc. $20.00 1
Teva Pharmaceuticals USA, Inc. $18.87 1
E.R. Squibb & Sons, L.L.C. $17.30 1
Medtronic, Inc. $16.90 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2023 $169.83 4
PY2024 $1,144.11 38

Payment records · PY2024 (38)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $22.31 01/10/2024 Food and Beverage Undisputed 01/23/2026 1106284924 CMS
ABBVIE INC. $17.83 02/21/2024 Food and Beverage Undisputed 01/23/2026 1106284926 CMS
ABBVIE INC. $18.53 03/28/2024 Food and Beverage Undisputed 01/23/2026 1106284928 CMS
ABBVIE INC. $19.18 04/11/2024 Food and Beverage Undisputed 01/23/2026 1106284930 CMS
ABBVIE INC. $16.91 05/02/2024 Food and Beverage Undisputed 01/23/2026 1106284932 CMS
ABBVIE INC. $17.34 07/24/2024 Food and Beverage Undisputed 01/23/2026 1106284934 CMS
ABBVIE INC. $21.30 08/14/2024 Food and Beverage Undisputed 01/23/2026 1106284936 CMS
ABBVIE INC. $6.29 09/04/2024 Food and Beverage Undisputed 01/23/2026 1106284938 CMS
ABBVIE INC. $17.78 10/24/2024 Food and Beverage Undisputed 01/23/2026 1106284940 CMS
ABBVIE INC. $8.04 11/06/2024 Food and Beverage Undisputed 01/23/2026 1106284942 CMS
ABBVIE INC. $17.24 11/16/2024 Food and Beverage Undisputed 01/23/2026 1106284944 CMS
Amgen Inc. $128.25 05/22/2024 Food and Beverage Undisputed 01/23/2026 1117407270 CMS
Amgen Inc. $7.86 06/12/2024 Food and Beverage Undisputed 01/23/2026 1111733787 CMS
Amgen Inc. $8.93 08/23/2024 Food and Beverage Undisputed 01/23/2026 1117407268 CMS
ANI Pharmaceuticals, Inc. $9.09 06/18/2024 Food and Beverage Undisputed 01/23/2026 1091142786 CMS
ANI Pharmaceuticals, Inc. $5.50 07/15/2024 Food and Beverage Undisputed 01/23/2026 1091137092 CMS
ANI Pharmaceuticals, Inc. $183.68 10/09/2024 Food and Beverage Undisputed 01/23/2026 1091169236 CMS
ANI Pharmaceuticals, Inc. $159.20 11/11/2024 Food and Beverage Undisputed 01/23/2026 1091166676 CMS
ANI Pharmaceuticals, Inc. $6.15 12/10/2024 Food and Beverage Undisputed 01/23/2026 1091132951 CMS
ARGENX US, INC. $28.74 11/04/2024 Food and Beverage Undisputed 01/23/2026 1142124611 CMS
E.R. Squibb & Sons, L.L.C. $17.30 04/19/2024 Food and Beverage Undisputed 01/23/2026 1101780679 CMS
LivaNova USA, Inc. $26.57 01/02/2024 Food and Beverage Undisputed 01/23/2026 1152790353 CMS
LivaNova USA, Inc. $17.44 05/31/2024 Food and Beverage Undisputed 01/23/2026 1152790323 CMS
LivaNova USA, Inc. $19.51 09/04/2024 Food and Beverage Undisputed 01/23/2026 1152790371 CMS
LivaNova USA, Inc. $27.15 10/07/2024 Food and Beverage Undisputed 01/23/2026 1152790399 CMS
LivaNova USA, Inc. $22.95 12/15/2024 Food and Beverage Undisputed 01/23/2026 1152790417 CMS
Medtronic, Inc. $16.90 08/28/2024 Food and Beverage Undisputed 01/23/2026 1119399366 CMS
Neurelis, Inc. $31.54 11/13/2024 Food and Beverage Undisputed 01/23/2026 1145657881 CMS
Novartis Pharmaceuticals Corporation $18.44 07/12/2024 Food and Beverage Undisputed 01/23/2026 1087436050 CMS
Novartis Pharmaceuticals Corporation $25.02 09/11/2024 Food and Beverage Undisputed 01/23/2026 1087436052 CMS
Novartis Pharmaceuticals Corporation $25.02 10/09/2024 Food and Beverage Undisputed 01/23/2026 1087436054 CMS
Novartis Pharmaceuticals Corporation $25.39 11/08/2024 Food and Beverage Undisputed 01/23/2026 1087436058 CMS
Octapharma USA, Inc. $20.00 03/21/2024 Food and Beverage Undisputed 01/23/2026 1142320408 CMS
Teva Pharmaceuticals USA, Inc. $18.87 05/24/2024 Food and Beverage Undisputed 01/23/2026 1151474051 CMS
UCB, Inc. $19.53 08/26/2024 Food and Beverage Undisputed 01/23/2026 1143121062 CMS
UCB, Inc. $19.49 09/30/2024 Food and Beverage Undisputed 01/23/2026 1143121064 CMS
UCB, Inc. $40.05 12/04/2024 Food and Beverage Undisputed 01/23/2026 1143121066 CMS
UCB, Inc. $32.79 12/09/2024 Food and Beverage Undisputed 01/23/2026 1143121068 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2023, 2024
Source files
Dataset page · Bulk file · PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.